Autolus Therapeutics (AUTL) EBT Margin Growth (5y) (2022 - 2025)

Autolus Therapeutics (AUTL) EBT Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.16 Mn
Sep 30, 2025 994,427.00
Jun 30, 2025 1.31 Mn
Mar 31, 2025 917,530.00
Mar 31, 2024 103,628.00
Sep 30, 2023 565,018.00
Dec 31, 2022 365,887.00